Table 1

MCV4 uptake during 2005 among 11-16 year old adolescents by MCO and age group

MCO

Local or state MCV4 Legislation^§

MCV4 shortage during 2005^§

Study Population

All adolescents Number (%) Vaccinated

Percent Vaccinated by Age Group

11-12

14-15

13+16

(Ref)

A

Yes^†

No

19724

3680

(18.7)

33.7*

13.8*

9.6

B

No

No

31404

9518

(30.3)

31.9*

32.0*

27.0

C

No

Yes

13456

1832

(13.6)

15.2*

13.4

12.3

D

Unknown^‡

Yes

261544

17934

(6.9)

6.4

7.7*

6.4

E

Unknown^‡

Yes

297761

31308

(10.5)

13.9*

10.3*

7.5

All MCOs

--

--

623889

64272

(10.3)

12.3*

10.5*

8.2

MCV4 - Meningococcal conjugate vaccine

MCO - Managed care organization

^§Based on self-report by principal investigator at each MCO

^†MCO is located in a state with legislation requiring meningococcal vaccination for adolescents in residential schools and postsecondary institutions that provide housing for students.

^‡MCO did not provide a response; however, the state(s) these MCOs are located in did(do) not have any meningococcal vaccination legislation[24].

*p < 0.001 when compared to 13+16 year group

Lorick et al. BMC Infectious Diseases 2009 9:175   doi:10.1186/1471-2334-9-175